ESC 365 - Targeting RNA elongation in endothelial-to-mesenchymal transition

ESC Professional Premium Access

Targeting RNA elongation in endothelial-to-mesenchymal transition

Session: RNA and gene therapy of vascular diseases

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Mr J. Hoba (Leipzig, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Julian Hoba

University of Leipzig, Leipzig (Germany)

0 follower

5 more presentations in this session

Overexpression of miR-210 ameliorates endothelial dysfunction in type 2 diabetic mice

Speaker: Doctor A. Collado (Stockholm, SE)

Dicer prevents activation of the type I interferon pathway in lipid-loaded macrophages

Speaker: Mr N. Li (Munich, DE)

Diagnostic ability of miR-19a and Let-7f along with platelet and leukocyte extracellular vesicles in acute ischemic stroke patients

Speaker: Mrs C. Eyileten (Warsaw, PL)

An in vivo CRISPR base editing therapy to inactivate the ANGPTL3 gene: nomination of a development candidate for VERVE-201

Speaker: Doctor A. Khera (Boston, US)

Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome

Speaker: Miss M. Noormalal (Kiel, DE)

Access the full session

RNA and gene therapy of vascular diseases

Speakers: Mr J. Hoba, Doctor A. Collado, Mr N. Li, Mrs C. Eyileten, Doctor A. Khera...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources